Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
about
Alemtuzumab for Multiple Sclerosis.Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in multiple sclerosis patients in Germany (TREAT-MS).Categorization of multiple sclerosis relapse subtypes by B cell profiling in the bloodMassive CNS monocytic infiltration at autopsy in an alemtuzumab-treated patient with NMO.Immunosuppressive Medications.Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis.An observational study of alemtuzumab following fingolimod for multiple sclerosis.Alemtuzumab: a new therapy for active relapsing-remitting multiple sclerosis.Both cladribine and alemtuzumab may effect MS via B-cell depletionThe histone variant H2A.Z promotes efficient cotranscriptional splicing in S. cerevisiae.Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies.Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program.Clinical pharmacology of alemtuzumab, an anti-CD52 immunomodulator, in multiple sclerosis
P2860
Q28069730-8895292C-233E-4144-BCD8-EF390F2053CBQ31115496-402026E2-1627-491E-9C88-AEF5BF8ED93EQ34253359-53A30EAE-4D21-4E8E-A97E-38595CA5C37DQ34376451-8C15EBAA-346B-4ED7-A4D5-CC19BC2774E9Q34484801-7C431FB4-E40A-433A-843E-A8003D089196Q37019872-9A00AF37-C239-4D8E-B085-3889E1620577Q37579941-CA7A80B8-7C1C-4ABF-A0CD-4A26660FFBBFQ38262622-C93373B3-44E5-4E95-8E4F-0B09F91358FAQ38720045-709D677F-F512-4B80-8924-ACDBEA77FC94Q38818037-9B48BBA3-D60A-4B9F-A44A-88EFBEFC5CE6Q39032832-FD1B34C6-ACEC-4BD1-B8F3-BD15DADA51A6Q39188128-92C8638F-C131-488E-A42F-758584DCD11AQ44757011-1503EAAD-A5D1-46CC-A5AF-8DDA045C5FFBQ59129976-9A8AE653-0B8D-4DF1-A394-D5CB33ECBA16
P2860
Insights into the Mechanisms of the Therapeutic Efficacy of Alemtuzumab in Multiple Sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Insights into the Mechanisms o ...... tuzumab in Multiple Sclerosis.
@en
type
label
Insights into the Mechanisms o ...... tuzumab in Multiple Sclerosis.
@en
prefLabel
Insights into the Mechanisms o ...... tuzumab in Multiple Sclerosis.
@en
P2093
P2860
P1476
Insights into the Mechanisms o ...... tuzumab in Multiple Sclerosis.
@en
P2093
Johanne M Kaplan
Mark S Freedman
Silva Markovic-Plese
P2860
P577
2013-07-01T00:00:00Z